Non-Invasive Imaging Biomarkers to Predict the Hepatopulmonary Shunt Fraction Before Transarterial Radioembolization in Patients with Hepatocellular Carcinoma
Hamm C, Busch F, Pöhlmann A, Shewarega A, He Y, Schmidt R, Xu H, Wieners G, Gebauer B, Savic L. Non-Invasive Imaging Biomarkers to Predict the Hepatopulmonary Shunt Fraction Before Transarterial Radioembolization in Patients with Hepatocellular Carcinoma. Journal Of Hepatocellular Carcinoma 2023, 10: 27-42. PMID: 36660411, PMCID: PMC9842483, DOI: 10.2147/jhc.s391537.Peer-Reviewed Original ResearchHepatopulmonary shunt fractionArterial phase enhancementTransarterial radioembolizationHepatocellular carcinomaOverall survivalCE-CTShunt fractionTechnetium-99m macroaggregated albuminImaging biomarkersInstitutional review board approvalM macroaggregated albuminIndependent risk factorClinically applicable risk scoreDisease-specific clinical parametersNon-invasive predictorPoor overall survivalReview board approvalNon-invasive imaging biomarkerTumor diameterNon-invasive predictionPoor OSTumor extentVenous invasionClinical parametersRetrospective study
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply